Brian Meeker
Family Medicine · Vinton, IANPI 1326023391
Payments from drug & device makers
Across 187 payments — averaging $16.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$326
- Amgen$300
- AbbVie$295
- Novartis$221
- Novo Nordisk$214
- AstraZeneca$173
- plus $1K from 29 others
What the payments were for
- Food & beverage$2,93497%
- Education$953%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 21 | $326 |
| Amgen | 20 | $300 |
| AbbVie | 19 | $295 |
| Novartis | 14 | $221 |
| Novo Nordisk | 12 | $214 |
| AstraZeneca | 10 | $173 |
| Sunovion Pharmaceuticals Inc. | 12 | $149 |
| Astellas Pharma US Inc | 4 | $139 |
| Lilly USA, LLC | 8 | $110 |
| Sanofi Pasteur Inc. | 6 | $107 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $103 |
| Boehringer Ingelheim | 5 | $94 |
| Phathom Pharmaceuticals, Inc. | 4 | $86 |
| Otsuka America Pharmaceutical, Inc. | 4 | $75 |
| Johnson & Johnson | 6 | $75 |
| Mylan Specialty L.p. | 3 | $50 |
| Exact Sciences | 3 | $48 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $43 |
| GSK | 3 | $40 |
| Axsome Therapeutics, Inc. | 2 | $36 |
| Alkermes, Inc. | 2 | $35 |
| Xeris Pharmaceuticals, Inc. | 2 | $35 |
| Harmony Biosciences LLC | 2 | $34 |
| Kowa Pharmaceuticals America, Inc. | 2 | $30 |
| Seqirus USA Inc | 2 | $27 |
| Biohaven Pharmaceuticals, Inc. | 2 | $27 |
| Merck | 1 | $21 |
| Dynavax Technologies Corporation | 1 | $20 |
| Dexcom, Inc. | 1 | $20 |
| Inspire Medical Systems, Inc. | 1 | $20 |
| Bayer | 1 | $19 |
| Genentech USA, Inc. | 1 | $16 |
| Abbott | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
How this compares
$3,029 in reported general payments places this provider in the 90th percentile of 1,357 family medicine providers in Iowa.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 270 | $161,736 |
| OzempicSemaglutide | 124 | $134,288 |
| JardianceEmpagliflozin | 159 | $129,910 |
| FarxigaDapagliflozin Propanediol | 84 | $55,085 |
| XareltoRivaroxaban | 55 | $42,536 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 61 | $42,062 |
| MyrbetriqMirabegron | 82 | $39,181 |
| Tresiba Flextouch U-100Insulin Degludec | 86 | $38,748 |
| RybelsusSemaglutide | 26 | $36,486 |
| TrulicityDulaglutide | 19 | $27,347 |
| MounjaroTirzepatide | 27 | $27,207 |
| JanuviaSitagliptin Phosphate | 29 | $24,286 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 15 | $23,948 |
| Spiriva HandihalerTiotropium Bromide | 34 | $18,668 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 61 | $18,459 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $214 | $170,774150 claims |
| PfizerEliquis | $326 | $161,736270 claims |
| Boehringer IngelheimJardiance, Combivent Respimat | $94 | $137,113174 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Brilinta | $173 | $80,569140 claims |
| Lilly USA, LLCTrulicity, Mounjaro, Humalog | $110 | $60,31875 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta | $40 | $56,84898 claims |
| Johnson & JohnsonXarelto | $75 | $42,53655 claims |
| Astellas Pharma US IncMyrbetriq | $139 | $39,18182 claims |
| MerckJanuvia | $21 | $24,28629 claims |
| NovartisEntresto | $221 | $7,09723 claims |
| AbbVieViibryd | $295 | $4,88726 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,357 family medicine providers in Iowa.
Other family medicine in Vinton
- Nicholas GoetschWaterloo$4.1M
- James PoockWaterloo$1.5M
- Jennifer KayCouncil Bluffs$613K
- Nicholas BechtoldSioux City$584K
- Kirk PetersonHuxley$576K
- Stephen HarrisonClinton$249K
- Sharon SteenBelle Plaine$241K
- Carlos Alarcon SchroderJohnston$237K
- Thomas RossDes Moines$170K
- Yogesh ShahDes Moines$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.